December 28, 2020
The Ministry of Health, Labor and Welfare (MHLW) on December 25 approved additional indications for a batch of medicines including Eli Lilly’s JAK inhibitor Olumiant (baricitinib) for the treatment of atopic dermatitis (AD) and MSD’s HPV vaccine Gardasil for use...read more